SK bioscience

본문바로가기

사이트맵 닫기

PR

SK bioscience company news updates

Press releases

SK bioscience Begins Shipment of First Authorized Protein-Based COVID-19 Vaccine

2022. 02. 09
SK bioscience Complete Recruitment for Phase III Clinical Trial of COVID-19 Vaccine

2022. 01. 18
SK bioscience Obtained Biologics License Application Approval of Novavax’ COVID-19 Vaccine in Korea

2022. 01. 12
SK bioscience-Novavax Extend Collaboration and Contract Manufacturing Agreements of COVID-19 Vaccine

2021. 12. 24
SK bioscience and CEPI Expand Partnership to Develop A New Universal Vaccine against variants of SARS-CoV and SARS-CoV-2

2021. 12. 21
SK bioscience Announces New Executive Promotions for 2022

2021. 12. 2
SK bioscience and Korea University Medicine Center Establish Partnership to Respond to Infectious Diseases

2021. 12. 2
SK bioscience Partners with IVI to Launch New Prestigious Award for Vaccine Industry

2021. 11. 30
SK bioscience Submits Biologics License Application to the KMFDS for Novavax Covid-19 Vaccine Candidate

2021. 11. 15
SK bioscience Announces Positive Data from Phase I/II Clinical Trial of COVID-19 Vaccine Candidate

2021. 11. 05